Jounce Therapeutics (NASDAQ: JNCE)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Jounce Therapeutics (NASDAQ: JNCE) through any online brokerage.
The latest price target for Jounce Therapeutics (NASDAQ: JNCE) was reported by Piper Sandler on Monday, May 23, 2022. The analyst firm set a price target for 9.00 expecting JNCE to rise to within 12 months (a possible 184.81% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Jounce Therapeutics (NASDAQ: JNCE) is $3.16 last updated June 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for Jounce Therapeutics.
Jounce Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Jounce Therapeutics.
Jounce Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.